{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:01:51Z","timestamp":1770822111738,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"9b","license":[{"start":{"date-parts":[[2008,6,9]],"date-time":"2008-06-09T00:00:00Z","timestamp":1212969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The objective of this prospective study was to compare the number of CIN2+cases detected in negative cytology by different quality control (QC) methods. Full rescreening, high\u2010risk (HR) human papillomavirus (HPV)\u2010targeted reviewing and HR HPV detection were compared. Randomly selected negative cytology detected by BD FocalPoint\u2122 (NFR), by guided screening of the prescreened which needed further review (GS) and by manual screening (MS) was used. A 3\u2010year follow\u2010up period was available. Full rescreening of cytology only detected 23.5% of CIN2+ cases, whereas the cytological rescreening of oncogenic positive slides (high\u2010risk HPV\u2010targeted reviewing) detected 7 of 17 CIN2+ cases (41.2%). Quantitative real\u2010time PCR for 15 oncogenic HPV types detected all CIN2+ cases. Relative sensitivity to detect histological CIN2+ was 0.24 for full rescreening, 0.41 for HR\u2010targeted reviewing and 1.00 for HR HPV detection. In more than half of the reviewed negative cytological preparations associated with histological CIN2+cases no morphologically abnormal cells were detected despite a positive HPV test. The visual cut\u2010off for the detection of abnormal cytology was established at 6.5 HR HPV copies\/cell. High\u2010risk HPV detection has a higher yield for detection of CIN2+ cases as compared to manual screening followed by 5% full review, or compared to targeted reviewing of smears positive for oncogenic HPV types, and show diagnostic properties that support its use as a QC procedure in cytologic laboratories.<\/jats:p>","DOI":"10.1111\/j.1582-4934.2008.00379.x","type":"journal-article","created":{"date-parts":[[2008,6,10]],"date-time":"2008-06-10T01:20:11Z","timestamp":1213060811000},"page":"4051-4060","source":"Crossref","is-referenced-by-count":13,"title":["Quality control for normal liquid\u2010based cytology: Rescreening, high\u2010risk HPV targeted reviewing and\/or high\u2010risk HPV detection?"],"prefix":"10.1111","volume":"13","author":[{"given":"Christophe E.","family":"Depuydt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina H.","family":"Benoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Vandepitte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie J.","family":"Vereecken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes J.","family":"Bogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,29]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"434","article-title":"Screening errors in cervical cytology screening","volume":"31","author":"Van der Graaf Y","year":"1987","journal-title":"Acta Cytol."},{"key":"e_1_2_6_3_2","first-page":"291","article-title":"Random rescreening of cytologic smears. A practical and effective component of quality assurance programs in both large and small cytology laboratories","volume":"38","author":"Krieger P","year":"1994","journal-title":"Acta Cytol."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000331549"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000333570"},{"key":"e_1_2_6_6_2","first-page":"493","article-title":"Medicare and CLIA programs. Amended 1988","volume":"57","author":"United States Department of Health and Human Services HCFA","year":"1992","journal-title":"Fed Regist"},{"key":"e_1_2_6_7_2","first-page":"9538","article-title":"Rules and regulations","volume":"55","author":"CLIA","year":"1990","journal-title":"Fed Regist"},{"key":"e_1_2_6_8_2","first-page":"461","article-title":"Reevaluation of quality assurance in the cytology laboratory","volume":"36","author":"Melamed MR","year":"1992","journal-title":"Acta Cytol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000333567"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.1993.tb00072.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.1995.tb00575.x"},{"key":"e_1_2_6_12_2","volume-title":"Report of the Working Party on the Internal Quality Control for Cervical Cytopathology Laboratories","author":"The Scottish Office","year":"1995"},{"key":"e_1_2_6_13_2","volume-title":"Achievable standards, benchmarks for reporting, and criteria for evaluating cervical cytopathology","author":"NHSCSP","year":"2000"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000328615"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10921"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000330863"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991225)87:6<354::AID-CNCR6>3.0.CO;2-F"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.1991.tb00504.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000330870"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000331546"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2114"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600756"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.2006.00386.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00073.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.2165\/00066982-200106010-00005"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20480"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602436"},{"key":"e_1_2_6_28_2","first-page":"6027","article-title":"A prospective study showing long\u2010term infection with human papillomavirus 16 before the development of cervical carcinoma in situ","volume":"60","author":"Ylitalo N","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02402-8"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02401-6"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10846"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602728"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1582-4934.2008.00379.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1582-4934.2008.00379.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T11:44:11Z","timestamp":1696160651000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1582-4934.2008.00379.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":32,"journal-issue":{"issue":"9b","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1582-4934.2008.00379.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00379.x","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}